Company profile
Cue Biopharma, Inc.
NASDAQ:CUEBiotechnology: Pharmaceutical Preparations
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03978689 | phase1 | completed | 2019-07-30 | 2026-01-04 | Cue Biopharma | A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma |
| NCT05360680 | phase1 | completed | 2022-06-14 | 2025-03-12 | Cue Biopharma | A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers |
FDA applications (0)
No records yet.